Sanofi and MannKind Corporation have entered into a worldwide exclusive licensing agreement for development and commerci…
Politics & Business
Why We Don’t Need A Soda Ban
Convincing the public to drink less soda has already proven effective. Consumption of soda has declined precipitously ov…
How the New York Times Could – And Should – Use Engaged Patients to Revolutionize Medical Reporting
The New York Times is one of the most respected and trusted papers in the country. It has the ability to affect policy a…
Stop Competitive Bidding for Insulin Pumps
We in the diabetes community need to speak out to argue that a. insulin pumps should be removed from competitive bidding…
Diabetes Supplies Urgently Needed for Philippines
It’s difficult to think about diabetes when people are also trying to survive without access to food, water and shelter,…
JDRF Invests $5 Million in T1D Innovations, New Diabetes Start-Up
JDRF and PureTech, a technology development company, have announced the launch of T1D Innovations, a novel venture-creat…
Obamacare and Diabetes: Will the Affordable Care Act Live Up to Its Promises?
Perhaps you are one of the millions of Americans currently wondering what is going to happen on October 1st, the day wh…
Why You Should Support The NYC Soda Ban
The idea behind the NYC soda ban is to restrict access to large sodas because they are widely seen as contributing to ob…
JDRF Announces New Executive Vice President of Research and Advocacy
JDRF announced today its new executive vice president of research and advocacy, David E. Wheadon, M.D. Dr. Wheadon bring…
The Boston Marathon Tragedy
Knowing someone you love is out there watching you makes every hard step a little less painful. But that’s all under th…
